Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Carcinoma, Merkel Cell × Cisplatin × Clear all

Phase

Status

Withdrawn 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 19 Squamous Cell Carcinoma of Head and Neck 10 Nasopharyngeal Carcinoma 10 Uterine Cervical Neoplasms 8 Small Cell Lung Carcinoma 6 Biliary Tract Neoplasms 5 Neoplasm Metastasis 4 Esophageal Squamous Cell Carcinoma 4 Stomach Neoplasms 3 Recurrence 3 Head and Neck Neoplasms 3 Endometrial Neoplasms 3 Urinary Bladder Neoplasms 2 Thymoma 2 Ovarian Neoplasms 2 Nasopharyngeal Neoplasms 2 Lung Neoplasms 2 Klatskin Tumor 2 Esophageal Neoplasms 2 Cholangiocarcinoma 2 Breast Neoplasms 2 Bile Duct Neoplasms 2 Unresectable Locally Advanced or Metastatic Solid Tumors 1 Thyroid Neoplasms 1 Thymic epithelial tumor 1 Squamous Cell Cancer of Head and Neck (SCCHN) 1 Solid Tumor Cancer 1 Sarcoma, Ewing 1 Rare Tumour 1 Pathologic Complete Response 1

Interventions

pembrolizumab 1 decitabine and cedazuridine drug combination 1 cemiplimab 1 Etoposide 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06086288 2023-10-17

PANDORA

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Not yet recruiting

Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡